Navigation Links
Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
Date:5/16/2013

SAN DIEGO, May 16, 2013 /PRNewswire/ -- The registration deadline has been extended until May 22 for the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, the premier conference for bioscience financial officers. The conference will be held May 28-31 at the Hilton San Diego Bayfront.

"We are putting the finishing touches on this year's conference and want to make sure as many people as possible have the opportunity to attend," said Brandi Roberts , Chief Financial Officer of Mast Therapeutics, Inc. and the 2013 National Conference Chair.

More than 140 financial leaders from life sciences companies have already registered for the conference.  The theme for the 2013 National Conference is "Creating and Capturing Value in Bioscience." The conference includes keynote speakers and breakout sessions all with a focus on value beyond just the areas of finance and accounting, encompassing operational excellence, business development, regulatory expertise and team building.  

Through keynote addresses and breakout sessions, ABFO will welcome numerous speakers, including:

  • Michael Abrashoff , Former Navy Commander and Author
  • Brian Baker , VP of Finance, Cleave Biosciences
  • Robert Baltera , Former CEO, Amira Pharmaceuticals , Inc.
  • Daniel Bradbury , Former CEO, Amylin Pharmaceuticals, Inc.
  • David Conway , Sr. Director Clinical Operations, Halozyme Therapeutics
  • Brian Culley , CEO, Mast Therapeutics, Inc.
  • Karin Eastham , Board Member – MorphoSys AG, Trius Therapeutics, Illumina, Crosswalk Press LLC, Geron
  • Mark Foletta , Former CFO, Amylin Pharmaceuticals, Inc.
  • Alan Fuhrman ,Chief Financial Officer, Ambit
  • Koji Fukumura , Partner, Cooley LLP
  • Carol Gallagher , Former President and CEO of Calistoga Pharmaceuticals
  • Greg Guarasci , Sr. VP of Clinical Operations, PRA International
  • Hans-Peter Guler , Sr. VP Clinical Development, Endocrine & Cardiovascular, INC. Research
  • Faheem Hasnain , President and CEO, Receptos
  • Kent Hawryluk , CEO, Tall Ship Group, LLC
  • Robert Hoffman , Senior Vice President, Finance and CFO, Arena Pharmaceuticals
  • Gary A. Holden , Director of Information Technology, Vical Incorporated
  • Jason Kent , Partner, Cooley LLP
  • Moisha Platto , VP Proposals & Finance, PRA International
  • Dr. Stanley Rockson , Chief of Consultative Cardiology at Stanford University School of Medicine
  • Killu Sanborn , Oxford Finance
  • Tamara A. Seymour , CFO, HemaQuest Pharmaceuticals, Inc.
  • Armen B. Shanafelt , Ph.D., Venture Partner, Lilly Ventures
  • Larry Smith , FASB Member
  • Phil Schneider , Former CFO, IDEC Pharmaceuticals
  • Lisa Thompson , Associate Director of Lean Enterprise Center of Excellence, Hologic | Gen-Probe
  • Will Waddell , Sr. Vice President, Chief Financial Officer, OncoMed Pharmaceuticals, Inc.
  • Robert Williamson , Founder, LaSalle Venture Advisers, Former Director, Pharmasset
  • Troy Wilson , President and CEO, Wellspring Biosciences LLC
  • Jerry Wright , Senior Vice President of Lean and Enterprise Excellence, DJO Global

Registration can be completed online at www.abfointernational.org/conference through May 22, 2013.  The cost to attend the conference is $1,300, and up to 18 hours of continuing education credits are available.  For more information about the conference, contact Brandi Roberts at broberts@mastthera.com.

Sponsors of the event include AON, Bank of America Merrill Lynch, Brinson Patrick , Ernst & Young, Oxford Finance and Cooley LLP.  The conference is also supported by Russo Partners, PR Newswire and BioCentury.

About the Association of Bioscience Financial Officers

Formed in 1989, the Association of Bioscience Financial Officers has eleven chapters that serve as forums for the exchange of information about the industry and networking. Regional chapters are based in top bioscience concentrations to allow for face-to-face meetings and discussion of hot topics of interest to bioscience financial officers. The regional chapters meet annually for the ABFO National Conference for extended networking. For more information, visit www.abfointernational.org.

Media Contact: 
Ian Stone or Monica May 
Russo Partners 
(619) 308-6541  
(619) 308-6542 
ian.stone@russopartnersllc.com 
monica.may@russopartnersllc.com


'/>"/>
SOURCE Association of Bioscience Financial Officers
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Registration Now Open for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego
3. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. Bayer CropScience Announces Registration for use of Alion on Grapes in California
6. Regulus Files Registration Statement for Proposed Initial Public Offering
7. National Defense Industrial Association (NDIA) Opens Registration For 2012 Biosurveillance Conference, Set For August 27-28 in Washington, D.C.
8. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
9. Registration now open: 2012 Regional, State, and Local Initiatives in Nanotechnology
10. ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseqâ„¢ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):